Skin microbiome analysis of a junctional epidermolysis bullosa patient treated with genetically modified stem cells
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2025
DOI: 10.1111/ddg.15776 ↗Kurz gefasst
Fallbericht in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2025. Verfasst von Alexander Dermietzel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, University Hospital Muenster, Muenster, Germany. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Epidermolysis Bullosa, Junctional, Genetic Therapy, Microbiota. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objective Junctional epidermolysis bullosa (JEB) is a subtype of epidermolysis bullosa caused by mutations in the LAMB3 gene. We treated a patient with JEB using genetically corrected autologous epidermal cultures retrovirally transduced with the functional LAMB3 gene sequence. The objective of this study was to analyze the skin microbiome of this patient, with a particular focus on transgenic skin, and to compare the findings to the skin microbiome of healthy controls and patients with atopic dermatitis and well‐documented microbial dysbiosis. Patients and Methods Skin microbiome analysis was performed on a JEB patient 72 months after combined gene and stem cell therapy. Skin swabs from age‐matched healthy controls and atopic dermatitis patients were included from the ProRaD study of CK‐CARE.
Results
The transgenic skin had comparably high relative and absolute Staphylococcus (S.) aureus abundance to blistering and non‐blistering skin of the JEB patient, while the total bacterial load was lower. In blistering skin of the JEB patient, higher bacterial load was driven by S. aureus .
Conclusions
Our investigation confirms a unique microbiome composition in JEB, characterized by S. aureus driven bacterial overgrowth. The dysbiosis was not reversed in transgenic, non‐blistering skin areas. However, the transgenic skin demonstrates stability in an environment of bacterial dysbiosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery, University Hospital Muenster, Muenster, Germany.
- Department of Plastic, Reconstructive, and Aesthetic Surgery, Hand Surgery, Fachklinik Hornheide, Muenster, Germany.
- Department of Plastic and Reconstructive Surgery, Institute for Musculoskeletal Medicine, University Muenster, Muenster, Germany.
- Department for Plastic, Reconstructive, and Aesthetic Surgery, Hand Surgery Rotenburg, Rotenburg, Germany.
- Institute of environmental medicine and integrative health, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
- Institute of Environmental Medicine, Helmholtz Munich, Augsburg, Germany.
ORCID-Profile: Claudia Hülpüsch
Zitieren
APA
Dermietzel, A., Tosun, B., Nguyen, M., Wessel, K., Rauer, L., Neumann, A. U., Hirsch, T., CK‐CARE study group, Traidl-Hoffmann, C., Reiger, M., Hülpüsch, C., & Kueckelhaus, M. (2025). Skin microbiome analysis of a junctional epidermolysis bullosa patient treated with genetically modified stem cells. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15776
Vancouver
Dermietzel A, Tosun B, Nguyen M, Wessel K, Rauer L, Neumann AU, et al. Skin microbiome analysis of a junctional epidermolysis bullosa patient treated with genetically modified stem cells. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025. doi:10.1111/ddg.15776
BibTeX
@article{Dermietzel2025,
author = {Dermietzel, Alexander and Tosun, Burcu and Nguyen, Mathilde and Wessel, Kai and Rauer, Luise and Neumann, Avidan U and Hirsch, Tobias and CK‐CARE study group, CK‐CARE study group and Traidl-Hoffmann, Claudia and Reiger, Matthias and Hülpüsch, Claudia and Kueckelhaus, Maximilian},
title = {Skin microbiome analysis of a junctional epidermolysis bullosa patient treated with genetically modified stem cells},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2025},
doi = {10.1111/ddg.15776}
}
EUVIMED